Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

News | EP Lab

Ventricular Tachycardia Recurrence, Hospitalization and Death Reduced With Catheter Ablation as First Line Therapy

August 9, 2021 – Results from an international clinical trial show a significant reduction in risk of ventricular ...

August 09, 2021

The Adagio Medical iCLAS cryoablation system is commercial in Europe and is also part of an ongoing FDA IDE trial in the U.S. #HRS21

News | Atrial Fibrillation

Pulsed Field Cryoablation Eliminated AF in 85% After Single Ablation Procedure

August 9, 2021 — Adagio Medical Inc., a provider of catheter ablation technologies for atrial fibrillation (AF) and ...

August 09, 2021

EP lab ablation catheter. #HRS21 #HRS2021

News | EP Lab

Patients With Atrial Fibrillation and Heart Failure Benefit From Early Rhythm Control

August 3, 2021 — A subgroup analysis of the EAST – AFNET 4 study population revealed early initiation of rhythm control ...

August 03, 2021

emporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation (AF) after coronary artery bypass (CAGB) surgery CABG without any adverse events in a randomized pilot study. The TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery (TerminationAF) study was presented as a late-breaking study presented at the 2021 Heart Rhythm meeting, the annual conference of the Heart Rhythm Society (HRS). #HRS21 #HRS2021

News | EP Lab

Spinal Cord Stimulation Helps Suppress AF in CABG Patients

August 4, 2021 — Temporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation ...

August 03, 2021

News | EP Lab

Oral Contraceptives Cause Increased Risk of Cardiac Events in Woman With Long QT Syndrome

August 3, 2021 – Results from a new clinical trial show an increased risk of cardiac events, like sudden cardiac death ...

August 03, 2021

A recent study unveiled a novel sinus node ablation technique that provides a safe and effective treatment option for patients suffering from symptomatic, drug-resistant inappropriate sinus tachycardia (IST). Results of the Susruta-IST Registry were presented as a late-breaking clinical trial at Heart Rhythm 2021, the annual meeting of the Heart Rhythm Society (HRS). #HRS21 #HRS2021

News | EP Lab

New Hybrid Ablation Technique Safe and Effective Treatment for Patients With Inappropriate Sinus Tachycardia

August 3, 2021 – A recent study unveiled a novel sinus node ablation technique that provides a safe and effective ...

August 03, 2021

The Philips EPD Kodex system for the EP lab.

News | EP Lab

Economic Analysis of CABANA Trial Reveals Economic Benefits of Catheter Ablation Compared to Drug Therapy

August 3, 2021 – A new analysis of the Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA ...

August 03, 2021

BIO-AffectDX is a multi-center, observational study that will enroll HF patients with paroxysmal, persistent and long-standing persistent AF, and a standard CRT-D indication. The study will include up to 400 participants implanted with a Biotronik Acticor CRT-DX system.

News | Cardiac Resynchronization Therapy Devices (CRT)

New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients With Atrial Fibrillation

August 3, 2021 — In association with Heart Rhythm 2021, Biotronik announced first enrollments in the landmark BIO ...

August 03, 2021

The Orchestra BioMed BackBeat Cardiac Neuromodulation Therapy (CNT) system is implanted similar to a pacemaker to stimulate the sympathetic nerves to help reduce blood pressure.

News | EP Lab

Significant and Sustained Reduction in Blood Pressure in MODERATO II Trial Using BackBeat Cardiac Neuromodulation Therapy in Crossover Patients

August 3, 2021 — Long-term follow-up data on hypertensive patients from the control group of the MODERATO II study who ...

August 03, 2021

Results of the STROKE-VT trial showed direct oral anticoagulants (DOACs) are more effective than aspirin in reducing cerebrovascular events, including stroke in patients undergoing ventricular tachycardia ablation.

News | EP Lab

Oral Anticoagulants After Catheter Ablation Helps Reduce Stroke in High-Risk Patients

July 29, 2021 – Results of the STROKE-VT trial shows direct oral anticoagulants (DOACs) are more effective than aspirin ...

July 29, 2021

The devices compared in the study were the Bardy Carnation Ambulatory Monitor long-term continuous ECG system (left) and the BioGuardian MCT cardiac event monitor (right). #HRS21 #HRS2021 #HeartRhythm21

News | EP Lab

Human ECG Monitoring Outperforms AI Dependent Remote Cardiac Monitoring

July 29, 2021 – Results from a new clinical trial found human-oversight dependent continuous electrocardiography (ECG) ...

July 29, 2021

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device.

News | Cardiac Diagnostics

Bardy Carnation Ambulatory Monitor Patch Decreases Diagnosis Time and Readmissions

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

July 29, 2021

Heart Rhythm Society, HRS, 2021 Late-Breaking Clinical Trials in Electrophysiology. #HRS #HRS2021 #HRS21 #Heartrhythm21

Feature | EP Lab

Heart Rhythm Society 2021 Late-Breaking Clinical Trials in Electrophysiology

July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them ...

August 09, 2021

Schematic illustration of a pre-vascularized stem cell patch having multiple stem cell-laden bio-inks to encorage heart cell regrowth at infarct areas. With permission from Elsevier. Read the original article.Jinah Jang, Reprinted from Biomaterials, Vol 112, Jinah Jang et al., 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair, Pages 264-274, Copyright (2017),

News | Medical 3-D Printing

Bioprinted 3D Cardiac Patches Could Reverse Scar Formation, Promote Myocardial Regeneration After Heart Attacks

July 27, 2021 -- Cardiovascular diseases account for 32% of global deaths. Myocardial infarction, or heart attacks, play ...

July 27, 2021

Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices (CIEDs) when the Tyrx Absorbable Antibacterial Envelope is used at implant. The analysis showed an 82% reduction in major CIED infections among patients with the Tyrx Envelope who developed hematomas compared to patients in the control group who developed hematomas.

News | EP Lab

Tyrx Absorbable Antibacterial Envelope Effectively Reduces Infections in Cardiac Device Patients with Hematomas

July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating ...

July 27, 2021